Effects of danazol on proliferation and viability of 7,12-dimethylbenz(a)anthracene-induced mammary tumours in rats

Anticancer research · 1995 · vol. 15(1) , pp. 61–5 · PMID:7733642 · W2414984558
Lab / animal OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-01 ⓘ

Danazol reduced viability and DNA synthesis in DMBA-induced mammary tumors in rats by suppressing hypothalamo-hypophysial-gonadal axis activity, lowering luteinizing hormone and estradiol levels.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The suppressive effects of danazol, an isoxazol derivative of a synthetic steroid 17 alpha-ethinyltestosterone, on cellular viability and DNA synthesis in 7,12-dimethylbenz(a)anthracene induced mammary tumours were investigated in adult female rats by enzyme assays and immunohistochemistry with bromodeoxyuridine (BrdU). Rats treated with danazol for 30 days showed a decrease of plasma levels of luteinizing hormone and estradiol associated with a dysfunction in hypothalamo-hypophysial-gonadal axis, resulting in lower activities in succinate dehydrogenase and thymidine kinase, and a reduction of BrdU-immunoreactive cells in mammary tumours compared with the control, i.e., decreases of viability and pyrimidine nucleotide synthesis in tumour cells in danazol-treated rats.

My notes (saved in your browser only)

MeSH descriptors

Cell Division Cell Survival Danazol Mammary Neoplasms, Experimental 9,10-Dimethyl-1,2-benzanthracene Animals Body Weight Body Weight Cell Division Cell Survival Corpus Luteum Corpus Luteum Corpus Luteum Danazol DNA, Neoplasm DNA, Neoplasm Estradiol Estradiol Estrus Estrus

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T11:14:29.518076+00:00
pubmed
last seen: 2026-10-08T21:59:01.426159+00:00
License: CC0 · commercial use OK